Summit Tx Capital, L.P. Terns Pharmaceuticals, Inc. Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q1 2025
A detailed history of Summit Tx Capital, L.P. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 100,133 shares of TERN stock, worth $290,385. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100,133Holding current value
$290,385% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TERN
# of Institutions
142Shares Held
85MCall Options Held
256KPut Options Held
133K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$23.7 Million1.87% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$21.9 Million0.65% of portfolio
-
Morgan Stanley New York, NY7.11MShares$20.6 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$20 Million5.17% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$16.2 Million0.54% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $109M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...